{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:20:12Z","timestamp":1786998012610,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007434","name":"Suzuken Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.waojou.2020.100447","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T13:52:55Z","timestamp":1597153975000},"page":"100447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Intranasal administration of regulatory dendritic cells is useful for the induction of nasal mucosal tolerance in a mice model of allergic rhinitis"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9555-0341","authenticated-orcid":false,"given":"Motohiko","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kanemitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.waojou.2020.100447_bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2217\/imt.11.48","article-title":"Subcutaneous versus sublingual immunotherapy for allergic rhinitis and\/or asthma","volume":"3","author":"Bahceciler","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.waojou.2020.100447_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/PPA.S3806","article-title":"Patient's compliance with allergen immunotherapy","volume":"2","author":"Incorvaia","year":"2008","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.waojou.2020.100447_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000071545","article-title":"Safety of allergen-specific sublingual immunotherapy and nasal immunotherapy","volume":"82","author":"Passalacqua","year":"2003","journal-title":"Chem Immunol Allergy"},{"key":"10.1016\/j.waojou.2020.100447_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1710-1492-2-3-117","article-title":"Local nasal specific immunotherapy for allergic rhinitis","volume":"2","author":"Passalacqua","year":"2006","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2172-11-60","article-title":"In\u00a0vivo trafficking and immunostimulatory potential of an intranasally-administered primary dendritic cell-based vaccine","volume":"11","author":"Vilekar","year":"2010","journal-title":"BMC Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib6","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.4049\/jimmunol.175.6.3900","article-title":"Efficacy of antigen 2\/proline-rich antigen cDNA-transfected dendritic cells in immunization of mice against Coccidioides posadasii","volume":"175","author":"Awasthi","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib7","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.jaci.2017.11.048","article-title":"Critical role of plasmacytoid dendritic cells in induction of oral tolerance","volume":"141","author":"Uto","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2012.02.014","article-title":"A\u00a0regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy","volume":"129","author":"Zimmer","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.imlet.2013.11.016","article-title":"Regulatory dendritic cell therapy: from rodents to clinical application","volume":"161","author":"Ra\u00efch-Regu\u00e9","year":"2014","journal-title":"Immunol Lett"},{"key":"10.1016\/j.waojou.2020.100447_bib10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/all.12203","article-title":"Regulatory dendritic cell expression of MHCII and IL-10 are jointly requisite for induction of tolerance in a murine model of OVA-asthma","volume":"68","author":"Huang","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100447_bib11","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2009.11.042","article-title":"A\u00a0novel allergen-specific therapy for allergy using CD40-silenced dendritic cells","volume":"125","author":"Suzuki","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2006.09.018","article-title":"Effects of intranasal versus oral hormone therapy on asymmetric dimethylarginine in healthy postmenopausal women: a randomized study","volume":"195","author":"Verhoeven","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.waojou.2020.100447_bib13","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.clinthera.2012.04.023","article-title":"Pharmacokinetic profile of beclomethasone dipropionate hydrofluoroalkane after intranasal administration versus oral inhalation in healthy subjects: results of a singledose, randomized, open-label, 3-period crossover study","volume":"34","author":"Ratner","year":"2012","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.waojou.2020.100447_bib14","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaci.2015.10.050","article-title":"Impaired barrier function in patients with house dust miteinduced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression","volume":"137","author":"Steelant","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.alit.2017.10.006","article-title":"Barrier dysfunction in the nasal allergy","volume":"67","author":"Fukuoka","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.waojou.2020.100447_bib16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0006-291X(02)02013-2","article-title":"Comparison of antisense oligonucleotides and siRNAs in cell culture and in\u00a0vivo","volume":"296","author":"Bertrand","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.waojou.2020.100447_bib17","first-page":"273","article-title":"Exon-specific RNA interference: a tool to determine the functional relevance of proteins encoded by alternatively spliced mRNAs","volume":"309","author":"Celotto","year":"2005","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.waojou.2020.100447_bib18","doi-asserted-by":"crossref","first-page":"6966","DOI":"10.1002\/anie.200701979","article-title":"Gene silencing by double-stranded RNA (Nobel lecture)","volume":"46","author":"Fire","year":"2007","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.waojou.2020.100447_bib19","doi-asserted-by":"crossref","first-page":"8461","DOI":"10.4049\/jimmunol.180.12.8461","article-title":"Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA","volume":"180","author":"Suzuki","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1398-9995.2008.01839.x","article-title":"Inhibition of allergic responses by CD40 gene silencing","volume":"64","author":"Suzuki","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.waojou.2020.100447_bib21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000489862","article-title":"Synergic effects of CD40 and CD86 silencing in dendritic cells on the control of allergic diseases","volume":"177","author":"Suzuki","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.alit.2016.08.014","article-title":"Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis","volume":"66","author":"Suzuki","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.waojou.2020.100447_bib23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaci.2017.02.038","article-title":"Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients","volume":"141","author":"Sugita","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4049\/jimmunol.141.2.489","article-title":"IL-4 induces co-expression of intrinsic membrane IgG1 and IgE by murine B cells stimulated with lipopolysaccharide","volume":"141","author":"Snapper","year":"1988","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2567.2007.02714.x","article-title":"Different types of in\u00a0vitro generated human monocytederived dendritic cells release exosomes with distinct phenotypes","volume":"123","author":"Johansson","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.waojou.2020.100447_bib26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fimmu.2015.00528","article-title":"Gene expression profiling of human monocytederived dendritic cells - searching for molecular regulators of tolerogenicity","volume":"6","author":"Schinnerling","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.waojou.2020.100447_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.waojou.2020.100447_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.waojou.2020.100447_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2004.07.004","article-title":"Dendritic cells exposed to estrogen in\u00a0vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis","volume":"156","author":"Pettersson","year":"2004","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.waojou.2020.100447_bib30","first-page":"4425","article-title":"Role of CCR7 on dendritic cellmediated immune tolerance in the airways of allergyinduced asthmatic rats","volume":"20","author":"Li","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.waojou.2020.100447_bib31","first-page":"109","article-title":"Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis","volume":"6","author":"Bridgeman","year":"2017","journal-title":"Integrated Pharm Res Pract"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455120303501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:42:10Z","timestamp":1761849730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455120303501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1939455120303501"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100447","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of regulatory dendritic cells is useful for the induction of nasal mucosal tolerance in a mice model of allergic rhinitis","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2020.100447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100447"}}